Assessment of sentinel lymph node in cervical cancer: Review of literature

Journal of Clinical Pathology

Volumn 62, Issue 12, 2009, Pages 1062-1065

  Rasty, G ^a   Hauspy, J ^b   Bandarchi, B ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; CANCER DIAGNOSIS; CLINICAL ASSESSMENT; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA; UTERINE CERVIX CANCER;

COLORING AGENTS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM; UTERINE CERVICAL NEOPLASMS;

EID: 73449087690     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2007.054031     Document Type: Review

References (57)

1. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics. CA Cancer J Clin 2001;51:15-36.
2. Sawaya GF, Grimes DA. New technologies in cervical cytology screening: a word of caution. Obstet Gynecol 1999;94:307-10.
3. Benedetti-Panici P, Maneschi F, Scambia, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996;62:19-24.
4. Delgado G, Bundy BN, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
5. Di Stefano AB, Acquaviva G, Garozzo G, et al. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. Gynecol Oncol 2005;99:671-9.
6. Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients radiated postoperatively for carcinoma of uterine cervix. Acta Radiol Oncol 1984;23:455-9.
7. Barranger E, Cortez A, Uzan S, et al. Value of intra-operative imprint cytology of sentinel node in patients with cervical cancer. Gynecol Oncol 2004;94:175-80.
8. Benedet JL, Odicino F, Maisonneuve WT, et al. Carcinoma of cervix uteri. J Epidemiol Biostat 2001;6:7-43.
9. Delgado G, Bundy BN, Fowler WC Jr, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989;35:314-20.
10. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
11. Lin YS, Tzeng CC, Huang KF, et al. Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer. Int J Gynecol Cancer 2005;15:273-7.
12. Magrina JF, Goodrich MA, Lidner TK, et al. Modified radical hysterectomy in the treatment of early squamous cervical cancer. Gynecol Oncol 1999;72:183-6.
13. Michel G, Morice P, Castaigne D, et al. Lymphatic spread in stage IB and II cervical carcinoma and surgical implications. Obstet Gynecol 1998;91:360-3.
14. Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with radical hysterectomy. Cancer 1999;85:1547-54.
15. Averette HE, Nguyen HN, Donato DM, et al. Radical hysterectomy for invasive cervical cancer. A 25-year prospective experience with the Miami technique. Cancer 1993;71(4 Suppl):1422-37.
16. Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005;(3):CD002225.
17. Potter ME, Alvarez RD, Shingleton HM, et al. Early invasive cervical cancer with pelvic node involvement: to complete or not to complete radical hysterectomy? Gynecol Oncol 1990;37:78-81.
18. Potter ME, Alvarez RD, Gay FL, et al. Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol 1990;37:74-7.
19. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
20. Rose PG, Adler LP, Rodriguez M, et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathological study. J Clin Oncol 1999;17:41-5.
21. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48.
22. Matsuura Y, Kawagoe T, Toki N, et al. Long-standing Complications after treatment for cancer of the uterine cervix: Clinical significance of medical examination at 5 years after treatment. Int J Gynecol Cancer 2006;16:294-7.
23. Scheidler J, Hricak H, Yu KK, et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 1997;278:1096-101.
24. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-51.
25. Morton DL, Wen Dr, Wong JH, et al. Technical details of intraoperative lymphatic mapping from early stage melanoma. Arch Surg 1992;127:392-9.
26. Gould EA, Winship T, Philbin PH, et al. Observation on a "sentinel node" in cancer of parotid. Cancer 1960;13:77-8.
27. Canabas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
28. Chiappa S, Uslenghi C, Bonadonna G, et al. Combined testicular and foot lymphangiography in testicular carcinomas. Surg Gynecol Obstet 1996;123:10-4.
29. Weissbach L, Boedefeld EA. Localization of solitary and multiple metastases in stage II nonseminematous testis tumors as basis for a modified staging lymph node dissection in stage I. J Urol 1987;138:77-82.
30. Echt ML, Finan MA, Hoffman MS, et al. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 1999;92:204-8.
31. Moore RG, DePasquale SE, Steinhoff MM, et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol Oncol 2003;89:475-9.
32. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
33. Medl M, Peters-Engl C, Schutz P, et al. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer. Anticancer Res 2000;20:1133-4.
34. Leveuf J, Godard H. Les lymphatiques de l'uterus. Rev Chir 1923;61:219-48.
35. Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 2000;79:411-5.
36. Silva LB, Silva-Filho AL, Traiman P, et al. Sentinel node detection in cervical cancer with (99 m) Tc-phytate. Gynecol Oncol 2005;97:588-95.
37. Plante M, Renaud MC, Tetu B, et al. Laparoscopic sentinel node mapping in early stage cervical cancer. Gynecol Oncol 2003;91:494-503.
38. Van de Lande J, Torrenga B, Raijmakers P, et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: A systematic review. Gynecol Oncol 2007;106:604-13.
39. Kettlewell S, Moyes C, Bray C, et al. Value of sentinel node status as a prognostic factor in melanoma. Prospective observational study. BMJ 2006;332:1423.
40. Borgstein PJ, Pijpers RJ, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
41. Hauspy J, Beiner M, Harley I, et al. Sentinel lymph nodes in early stage cervical cancer. Gynecol Oncol 2007;105:285-90.
42. O'Boyle JD, Coleman RL, Bernstein SG, et al. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 2000;79:238-43.
43. Martinez-Palones JM, Gil-Moreno A, Perez-Benatvente MA, et al. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol 2004;92:845-50.
44. Gil-Moreno A, Diaz-Feijoo B, Roca I, et al. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol Oncol 2005;96:187-93.
45. Lambaudie E, Collinet P, Narducci F, et al. Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer prospective study using the combination of patent blue dye in injection and technetium radiocolloid injection. Gynecol Oncol 2003;89:84-7.
46. Machiole P, Buenerd A, Scoazec JY, et al. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 2004;100:2154-9.
47. 99mTc phytate and patent blue. Gynecol Oncol 2004;94:528-32.
48. Levenback C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002;20:688-93.
49. Roca I, Caresia P, Gil-Moreno A, et al. Usefulness of sentinel lymph node detection in early stages of cervical cancer. Eur J Nucl Med Mol Imaging 2004;31:479-86.
50. Van Dam P, Hauspy J, Vanderheyden T, et al. Intraoperative sentinel node identification with technetium-99m-labeled nanocolloid in patients with cancer of uterine cervix: A feasibility study. Int J Gynecol Cancer 2003;13:182-6.
51. Euscher E, Malpica A, Atkinson EN, et al. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol 2008;32:1336-43.
52. Juretzka M, Jensen K, Longacre T, et al. Detection of pelvic lymph node micrometastases in stage 1A2-1B2 cervical cancer by immunohistochemical analysis. Gynecol Oncol 2004;93:107-11.
53. Lentz SE, Muderspah LI, Felix JC, et al. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. Obstet Gynecol 2004;103:1204-10.
54. Coutant C, Barranger E, Cortez A, et al. Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer. Ann Oncol 2007;18:1513-7.
55. Bergstrom KG. Rethinking squamous cell carcinoma; which are high risk, which could benefit from lymph node dissection, what's coming up in the future? J Drugs Dermatol 2008;7:903-6.
56. Horn LC, Hentschel B, Fischer U, et al. Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: Frequency, topographic distribution and prognostic impact. Gynecol Oncol 2008;111:276-81.
57. Ayhan A, Celik H, Dursun P. Lymphatic mapping and sentinel node biopsy in gynaecological cancers: a critical review of the literature. World J Surg Oncol 2008;6:53.